Comparison Between Activated Partial Thromboplastin Time and Anti-Xa Heparin Assays on Patients on Unfractionated Heparin Therapy

被引：0
|
作者：
Pearlman, Eugene [1 ]
Bibars, Wafi [2 ]
Willard, Jennifer [3 ]
Moore, Darlene [3 ]
机构：
[1] Vet Affairs Med Ctr, Memphis, TN USA
[2] Univ Tennessee, Hlth Sci Ctr, Knoxville, TN 37996 USA
[3] Vet Affairs Med Ctr Memphis, Memphis, TN USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2015年 / 144卷
关键词：
D O I：
10.1093/ajcp/144.suppl2.127
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
127
引用
收藏
页码：A127 / A127
页数：1
相关论文
共 50 条
  • [41] Effects of apixaban on prothrombin time, activated partial thromboplastin time and anti-Xa assays: a European survey
    Helin, Tuukka A.
    Pakkanen, Anja
    Lassila, Riitta
    Joutsi-Korhonen, Lotta
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2017, 55 (08) : E178 - E180
  • [42] Monitoring unfractionated heparin therapy: Lack of standardization of anti-Xa activity reagents
    Smahi, Motalib
    De Pooter, Neila
    Hollestelle, Martine J.
    Toulon, Pierre
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (10) : 2613 - 2621
  • [43] SAFETY OF MONITORING UNFRACTIONATED HEPARIN INFUSIONS IN CRITICALLY ILL PATIENTS: ANTI-FACTOR XA VERSUS ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)
    Burka, Abigail
    Cunningham, Michael
    Ernst, Neil
    Droege, Chris
    Hillebrand, Kristen
    Clark, Lindsey
    Tsuei, Betty
    Mueller, Eric
    CRITICAL CARE MEDICINE, 2012, 40 (12) : U279 - U279
  • [44] Puerperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparin - Reply
    Greer, IA
    Walker, ID
    Gibson, JE
    Ekevall, K
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1999, 106 (06): : 615 - 615
  • [45] Establishing the heparin therapeutic range using aPTT and anti-Xa measurements for monitoring unfractionated heparin therapy
    Byun, Jung-Hyun
    Jang, In-Seok
    Kim, Jong Woo
    Koh, Eun-Ha
    BLOOD RESEARCH, 2016, 51 (03) : 171 - 174
  • [46] The missing slope: paradoxical shortening of activated partial thromboplastin time in a patient on unfractionated heparin therapy
    Lapic, Ivana
    Vrancic, Ana Loncar
    Herak, Desiree Coen
    Rogic, Dunja
    BIOCHEMIA MEDICA, 2021, 31 (02) : 021003
  • [47] Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy
    Lawlor, Matthew
    Gupta, Aakriti
    Ranard, Lauren S.
    Madhavan, Mahesh V.
    Li, Jianhua
    Eisenberger, Andrew
    Parikh, Sahil A.
    Sethi, Sanjum S.
    Masoumi, Amirali
    THROMBOSIS RESEARCH, 2021, 198 : 79 - 82
  • [48] ACTIVATED PARTIAL THROMBOPLASTIN TIME AS A CONTROL IN HEPARIN THERAPY
    HARMELING, JG
    CORDRAY, DR
    SOUTHERN MEDICAL JOURNAL, 1967, 60 (06) : 594 - +
  • [49] MONITORING HEPARIN THERAPY WITH ACTIVATED PARTIAL THROMBOPLASTIN TIME
    STUART, RK
    MICHEL, A
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1971, 104 (05) : 385 - &
  • [50] Comparison of Activated Partial Thromboplastin Time (aPTT) and Anti-Factor Xa for Low Intensity Unfractionated Heparin Monitoring in Patients with Mechanical Circulatory Support Devices (MCSD)
    Volod, O.
    Lam, L. D.
    Barglowski, M.
    Mirocha, J.
    Runyan, C.
    Moriguchi, J.
    Czer, L. S.
    Arabia, F.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S443 - S443
12345